Servier Polska

Servier Polska, established in 1992, is a significant player in the pharmaceutical sector, dedicated to drug production and advanced clinical research. The company focuses its efforts on critical therapeutic areas including cardiology, oncology, immuno-inflammatory diseases, and neurology, developing prescription medications and specialized oncological therapies designed to enhance patient outcomes. With a commitment to European quality standards, Servier Polska ensures that 98% of its active pharmaceutical substances are manufactured within the European Union, underscoring its dedication to quality and regional supply chain integrity. The company operates with a workforce of 500-1,000 employees and generates an annual revenue of $46.8M. Meet Servier Polska's team to gain insight into their operational structure and leadership.

Servier Polska's operational philosophy extends beyond product development to encompass robust social engagement, stringent ethical practices, and a commitment to sustainable development. They actively provide valuable educational resources and user-friendly mobile applications tailored for both patients and healthcare professionals, aiming to foster better health management and information accessibility. The company's strategic focus on innovation and patient well-being positions it as a key contributor within its specialized markets. Despite its primary focus on pharmaceuticals, its listed industry also includes Manufacturing and Computer Equipment & Peripherals, reflecting a potentially diversified operational scope or historical classification.

The company's presence is marked by a singular operational location, emphasizing a concentrated approach to its core functions. Servier Polska's dedication to advancing medical science and improving public health is evident in its comprehensive approach, integrating research, production, and patient support services. Their adherence to high-quality manufacturing processesView more...